• About us
  • Focus areas
  • Research & Development
    • Therapeutic areas
      • Cardiology
        • Early discovery
        • In vitro
        • In vivo
        • Phase I
        • Clinical
      • Bone & cartilage
        • Early discovery
        • In vitro
        • In vivo
        • Phase I
        • Clinical
      • Oncology
        • Early discovery
        • In vitro
        • In vivo
        • Clinical
      • Neurology
        • Neuroendocrinology
          • Early discovery
          • In vivo
          • Phase I
        • Inner ear / Deafness
          • Early discovery
          • In vitro
          • In vivo
          • Phase I
        • Glioblastoma
          • Early discovery
          • In vitro
          • In vivo
          • Clinical
        • Epilepsy
          • Early discovery
          • In vitro
          • In vivo
          • Phase I
          • Clinical
        • Spinal Cord / Multiple Sclerosis
          • Early discovery
          • In vitro
          • In vivo
          • Phase I
          • Clinical
        • Alzheimer’s disease
          • Early discovery
          • In vitro
          • In vivo
          • Phase I
          • Clinical
        • Parkinson’s disease
          • Early discovery
          • In vitro
          • In vivo
          • Phase I
          • Clinical
    • Development stages
      • Early discovery
        • Cardiology
        • Bone & cartilage
        • Oncology
        • Neurology
          • Neuroendocrinology
          • Inner ear / Deafness
          • Glioblastoma
          • Epilepsy
          • Spinal Cord / Multiple Sclerosis
          • Alzheimer’s disease
          • Parkinson’s disease
      • In vitro
        • Cardiology
        • Bone & cartilage
        • Oncology
        • Neurology
          • Neuroendocrinology
          • Inner ear / Deafness
          • Glioblastoma
          • Epilepsy
          • Spinal Cord / Multiple Sclerosis
          • Alzheimer’s disease
          • Parkinson’s disease
      • In vivo
        • Cardiology
        • Bone & cartilage
        • Oncology
        • Neurology
          • Neuroendocrinology
          • Inner ear / Deafness
          • Glioblastoma
          • Epilepsy
          • Spinal Cord / Multiple Sclerosis
          • Alzheimer’s disease
          • Parkinson’s disease
      • Phase I
        • Cardiology
        • Bone & cartilage
        • Oncology
        • Neurology
          • Neuroendocrinology
          • Inner ear / Deafness
          • Glioblastoma
          • Epilepsy
          • Spinal Cord / Multiple Sclerosis
          • Alzheimer’s disease
          • Parkinson’s disease
      • Clinical
        • Cardiology
        • Bone & cartilage
        • Oncology
        • Neurology
          • Neuroendocrinology
          • Inner ear / Deafness
          • Glioblastoma
          • Epilepsy
          • Spinal Cord / Multiple Sclerosis
          • Alzheimer’s disease
          • Parkinson’s disease
      • Medical device
        • Cardiology
        • Bone & cartilage
        • Oncology
        • Neurology
          • Neuroendocrinology
          • Inner ear / Deafness
          • Glioblastoma
          • Epilepsy
          • Spinal Cord / Multiple Sclerosis
          • Alzheimer’s disease
          • Parkinson’s disease
  • Technologies
    • OMICS
    • Protein engineering
    • Animal Facility
    • Imaging
    • Drug Discovery
    • Drug Development
    • Bio-analyses
    • Motion Analysis
    • Clinical Support
    • Other
  • Opportunities
  • For researchers
  • News
  • Contact
  • +32 4 242 77 91
  • info@b2h.be
  • Follow us on LinkedIn
ULg CHU - Centre Hospitalier Universitaire de Liège

Welcome to B2H Intranet

COMMING SOON

Thank you for your interest. Give here your contact details and you'll receive an email with the pdf file you request.

loading
Please check the mandatory fields.
An error occured. Please send an e-mail to info@b2h.be, thank you.
Thank you, check your mailbox. You just received an email.
Other services

Research & Development

We have developed inertial motion sensors for the ambulatory quantification of walking and other movements.

A vast and untapped resource of academic excellence in healthcare is at your service !

B2H - unlocking healthcare solutions

GIGA CIP Cyclotron CIRM
© 2018 Bridge 2 Health - Providing Solutions Leveraging Excellence   —   website by In Fine Digital

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

I accept I decline
Privacy Settings Cookie Policy
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

Tracking Privacy Policy Cookie Policy
Google Analytics
We track anonymized user information to improve our website.
  • _ga 2 year
  • _gid 24 hours
  • _gat 1 minute
  • AMP_TOKEN 30 seconds to 1 year
  • _gac_ 90 days
Decline all Services
Accept all Services